Flash FinanceUS
Pre-market S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Electra Therapeutics, Inc. (ETRA)

Electra Therapeutics closes $350.0 million IPO at $15.00 per share and adopts new charter

Neutral Impact 4 of 5 financing Written later

Electra Therapeutics, Inc. closed its initial public offering on September 21, 2026, selling 23,333,334 shares of common stock at $15.00 per share, for approximately $350.0 million in gross proceeds before underwriting discounts and offering expenses. The company also filed an amended and restated certificate of incorporation and adopted amended and restated bylaws effective on the closing date.

Key points

  • IPO: 23,333,334 shares of common stock sold at $15.00 per share
  • Gross proceeds of approximately $350.0 million before underwriting discounts and estimated offering expenses
  • Restated certificate of incorporation filed with Delaware and restated bylaws adopted, both effective September 21, 2026
  • Full terms are described in the final prospectus filed September 18, 2026 under Rule 424(b)

The filing

CompanyElectra Therapeutics, Inc. (ETRA)
Form8-K, current report
Filed with the SECSep 21, 2026, 4:01 PM ET
Accession number0001193125-26-396646

Items reported: 5.03 Bylaw / Charter Amendment8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.